全关节置换术后减少阿片类药物处方量可在不增加并发症的情况下安全实施
该研究基于全州前瞻性数据库,纳入阿片处方方案制定前后各1年的84,998例全关节置换术,该方案使出院阿片处方量减少约50%。结果显示所有组阿片处方量减少近50%,急诊就诊和再入院未增加,患者报告结局未受损,部分组别还有显著改善。结论认为全关节置换术后减少阿片处方可安全实施且不增加并发症。
要点
- 全州阿片处方方案使全关节置换术后阿片处方量减少约50%。
- 处方减少后急诊就诊和再入院未增加,患者报告结局未受损。
- 部分初用阿片组患者报告结局还有显著改善。
核心结论
- 全州注册数据库的术后阿片处方建议使处方量减少约50%,患者报告结局未下降,急诊就诊或再入院未增加。
- 全关节置换术后减少阿片处方可安全完成且不增加并发症。
研究设计与样本
- 数据来自全州数据库的前瞻性摘录,包含出院时口服吗啡当量、再入院、急诊就诊和患者报告结局。
- 数据收集自阿片处方方案制定前后各1年的84,998例全关节置换术,该方案使处方量减少约50%。
- 使用休哈特控制图监测趋势,回归模型确定随时间变化的统计学显著变化。
主要发现
- 所有组阿片处方量减少近50%,急诊就诊或再入院未增加,患者报告结局未受损。
- 与阿片减少前基线数据相比,初用阿片的全膝关节置换术所有结局均有显著改善(P = .03、P = .02、P < .001、P < .001)。
- 耐受阿片的全膝关节置换术和全髋关节置换术结局未恶化,且全膝关节置换术的膝关节损伤与骨关节炎结局评分关节置换版(P = .03)和全髋关节置换术的髋关节残疾与骨关节炎结局评分关节置换版(P = .03)显著改善。
- 初用阿片的全髋关节置换术髋关节残疾与骨关节炎结局评分关节置换版(P = .003)和患者报告结局测量信息系统(P = .001)显著改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Excessive opioid prescriptions after total joint arthroplasty (TJA) increase risks for adverse opioid-related events, chronic opioid use, and unlawful opioid diversion. Decreasing postoperative prescriptions may improve quality after TJA. Concerns exist that a decrease in opioids prescribed may increase complications, such as readmissions, emergency department (ED) visits, or worsened patient-reported outcomes (PROs). The purpose of this study was to explore whether a reduction in opioids prescribed after TJA resulted in increased complications. METHODS: Data originated from a statewide database prospectively abstracted, including oral morphine equivalents prescribed at discharge, readmissions, ED visits, and PROs. Data were collected from 84,998 TJA occurring 1 year before and after the creation of an opioid-prescribing protocol that had decreased prescriptions by approximately 50%. Trends were monitored using Shewhart control charts. Regression models were used to determine statistically significant changes over time. RESULTS: All groups showed a reduction in opioids prescribed by almost 50% without an increase in emergency room visits or readmissions and without a detrimental effect on PROs. Compared to baseline data before opioid reduction, opioid-naive total knee arthroplasty had significant improvements in all outcomes (P = .03, P = .02, P < .001, P < .001). Opioid-tolerant total knee arthroplasty and total hip arthroplasty had no worsened outcomes and significant improvement in (Knee Injury and Osteoarthritis Outcome score for Joint Replacement P = .03) and (Hip Disability and Osteoarthritis Outcome Score for Joint Replacement P = .03). Opioid-naive total hip arthroplasty had significant improvements in Hip Disability and Osteoarthritis Outcome Score Joint Replacement (P = .003) and Patient Reported Outcomes Measurement Information System (P = .001). CONCLUSIONS: Postoperative opioid prescription recommendations from a statewide registry decreased prescribing by approximately 50% without decreasing PROs or increasing ED visits or readmissions. A reduction in opioids prescribed after TJA can be accomplished safely and without increased complications.
引用
- Wenzlick TS, Kutzner AR, Markel DC, et al. A Reduction in Opioid Prescription Size After Total Joint Arthroplasty Can be Safely Performed Without an Increase in Complications. J Arthroplasty. 2023. PMID: 36828049. doi:10.1016/j.arth.2023.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。